Cargando…
Levetiracetam Mechanisms of Action: From Molecules to Systems
Epilepsy is a chronic disease that affects millions of people worldwide. Antiepileptic drugs (AEDs) are used to control seizures. Even though parts of their mechanisms of action are known, there are still components that need to be studied. Therefore, the search for novel drugs, new molecular target...
Autores principales: | Contreras-García, Itzel Jatziri, Cárdenas-Rodríguez, Noemí, Romo-Mancillas, Antonio, Bandala, Cindy, Zamudio, Sergio R., Gómez-Manzo, Saúl, Hernández-Ochoa, Beatriz, Mendoza-Torreblanca, Julieta Griselda, Pichardo-Macías, Luz Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030752/ https://www.ncbi.nlm.nih.gov/pubmed/35455472 http://dx.doi.org/10.3390/ph15040475 |
Ejemplares similares
-
Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model
por: Ignacio-Mejía, Iván, et al.
Publicado: (2023) -
Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment
por: Contreras-García, Itzel Jatziri, et al.
Publicado: (2021) -
Levetiracetam Reduced the Basal Excitability of the Dentate Gyrus without Restoring Impaired Synaptic Plasticity in Rats with Temporal Lobe Epilepsy
por: González-H, Guillermo, et al.
Publicado: (2020) -
Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies
por: Bandala, Cindy, et al.
Publicado: (2023) -
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis
por: Mendoza-Torreblanca, Julieta Griselda, et al.
Publicado: (2023)